You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Boehringer Ingelheim
Colorcon
Express Scripts

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for DIVX, LLC v. Netflix, Inc. (C.D. Cal. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

DIVX, LLC v. Netflix, Inc. (C.D. Cal. 2019)

Docket   Start Trial Date Filed 2019-03-05
Court District Court, C.D. California Date Terminated 2020-05-11
Cause 28:1338 Patent Infringement Assigned To Philip S. Gutierrez
Jury Demand Plaintiff Referred To Douglas F. McCormick
Parties DIVX, LLC; NETFLIX, INC.
Patents 10,588,844; 7,410,945; 7,943,310; 8,299,106; 9,498,528
Attorneys Aaron R Fahrenkrog; Andrew M Holmes; Brian P Biddinger; Bryan J Mechell; Christopher A Seidl; Daniel Lewis Allender; David A Perlson; David M Stein; Emily J Tremblay; Lance L Yang; Mary Pheng; Rajin S Olson; Roman M Silberfeld; Shui Li; Valerie Anne Lozano; William E Manske
Firms Greenberg Gross LLP; Quinn Emanuel Urquhart & Sullivan LLP; Quinn Emanuel Urquhart & Sullivan, LLP; Quinn Emanuel Urquhart Oliver & Hedges LLP; Robins Kaplan LLP
Link to Docket External link to docket
Biologic Drugs cited in DIVX, LLC v. Netflix, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for DIVX, LLC v. Netflix, Inc. (C.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-04-27 102 Response in Opposition to Motion 12 U.S. Patent No. 10,225,588 (Dkt. 60-8) ’588 patent or ’588 … 10 U.S. Patent No. 9,270,720 (Dkt. 60-5) ’720 patent or ’720 R OBINS K APLAN… Netflix adopted DivX’s patented 10 technologies and leveraged…challenges to DivX’s patents will never 10 completely resolve…Notably, the patent owner in ASCII initiated the USPTO 10 proceedings External link to document
2020-05-11 106 Stay Case the completion of co-pending patent office proceedings. See ASCII, 844 F. Supp. at 1380. Second, and… 2020 September 2020 10,225,588 Yes Yes …. STD Entm’t USA, Inc., 844 F. Supp. 1378, 1380 (N.D. Cal. 1994). CV-90 (10/08) …infringement for that asserted patent.” Netflix Mot. 1 n.1. CV-90 (10/08) …defend its patents with objective considerations of non- obviousness. CV-90 (10/08) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Medtronic
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.